Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 195

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 195
---
 common shares outstanding - basic and diluted                                                |     |                         |  1,866,275 |   |     |              |  1,337,742 |   |
| Net loss per share - basic and diluted                                                                        |     |                         |      (3.53 | ) |     |              |      (5.04 | ) |

<div align='center'>The accompanying notes are an integral part of these consolidated financial statements.</div>

| F-23 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Years Ended December 31, 2023 (as restated) and 2022 (as restated)</div>

|                                                                                                                 |     | Shares            
 Series            
 A Preferred Stock 
 Shares            |        |   |     | Amount 
 Amount |   |     | Shares 
 Common 
 Stock  
 Shares |           |     | Amount 
 Amount |    |     | Capital 
 Paid-In 
 Capital |            |   |     | Issued 
 Common 
 Stock  
 to     
 be     
 Issued |         |   |     | Deficit     
 Accumulated 
 Deficit     |             |   |     | Equity        
 Total         
 Stockholders’ 
 Equity        |            |   |
|:----------------------------------------------------------------------------------------------------------------|:----|:------------------|-------:|:--|:----|:-------|:--|:----|:-------|----------:|:----|:-------|---:|:----|:--------|-----------:|:--|:----|:-------|--------:|:--|:----|:------------|:------------|:--|:----|:--------------|-----------:|:--|
| Balance at December                                                                                             
 31, 2021 (as restated)                                                                                          |     |                   |  1,213 |   |     | $      | — |     |        | 1,164,039 |     | $      | 12 |     | $       | 12,063,940 |   |     | $      |  16,340 |   |     | $           | (13,844,512 | ) |     | $             | (1,764,220 | ) |
| Common                                                                                                          
 stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated |     |                   |      — |   |     |        | — |